THOROUGHBRED HORSES 
61 pages
Published: 1 Apr 2008
Author(s): Spendlove, P, Hodgson, J, Hodgson, D
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
This report delivers the findings of a study to assess the efficacy of inhalational pharmaceutical treatment options for treatment of lower airway inflammation (LAI) in young performance horses housed intensively in stables, and additionally to review the contributions of various environmental sources for known airway irritants. Information on both management and pharmaceutical intervention for this syndrome is provided.
The re-emergence of foot and mouth disease (FMD) in Indonesia in 2022 has emphasised the need for Australia to be prepared for a potential incursion....
In the wake of the 2022 foot and mouth disease (FMD) resurgence in Indonesia, there is a critical need for Australia to be prepared in...
The Australian thoroughbred breeding industry continues to grapple with managing risks related to Rhodococcus equi pneumonia, commonly known as ‘rattles’. The disease compromises foal health...
Infectious diseases can cause significant equine illness and death, seriously impacting the productivity of the Australian thoroughbred breeding industry and incurring economic losses. One well-known...
The Australian thoroughbred breeding industry is second in size only to that of the United States, with 660 stud farms predominantly in New South Wales,...
Equine herpes virus (EHV) is a DNA virus found in horses all around the world. There are different strains of EHV, with the most common...
Exposure to hairy processionary caterpillars (Ochrogaster lunifer), or their nest material, can damage tissues in the amnion, umbilical cord and placenta of developing fetuses, resulting...
Exposure to fetal material and bodily fluids poses a significant risk of spreading and contracting infectious diseases carried by pregnant mares. Monitor, test and suit-up...
